BIIB
Biogen Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website biogen.com
- Employees(FY) 8725
- ISIN US09062X1037
Performance
-1.44%
1W
+2.47%
1M
+2.33%
3M
-13.48%
6M
-13.75%
YTD
-20.74%
1Y
Profile
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It also provides RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, immunology related diseases, neurovascular disorders, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. Biogen Inc. has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Investment Analysis Report: Biogen Inc. (BIIB)
Overview
Biogen Inc. (BIIB) operates in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $32.46 billion. In this report, we will conduct a comprehensive analysis of BIIB's financial health, valuation, earnings and revenue g...
Technical Analysis of BIIB 2024-05-31
Overview:
In analyzing the technical indicators for BIIB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...
Recent News & Updates
- 2024-06-25 20:37
- 2024-06-25 08:37
- 2024-06-24 21:50
- 2024-06-24 09:50
- 2024-06-24 07:30
- 2024-06-23 19:30
- 2024-06-19 12:11
- 2024-06-17 07:00
Two Is Better Than One in the Alzheimer’s Market(The Wall Street Journal)
- 2024-06-17 01:12
ALS pipeline suffers a major hit as Biogen’s Tofersen fails phase iii trial(Clinical Trials Arena)
- 2024-06-16 04:00
The 3 Best Healthcare Stocks to Buy in June 2024(Investorplace)
- 2024-06-14 18:45
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover(Morningstar Research)
- 2024-06-14 11:21
- 2024-06-14 11:10
- 2024-06-13 17:45
- 2024-06-13 06:09
- 2024-06-12 10:22
- 2024-06-12 04:07
- 2024-06-11 12:25
- 2024-06-11 12:20
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win(Investor's Business Daily)
- 2024-06-11 09:29
- 2024-06-11 08:22
- 2024-06-11 04:18
- 2024-06-10 21:54
- 2024-06-10 20:45
- 2024-06-10 19:35
5 Things to Know Before the Stock Market Opens(Investopedia)
- 2024-06-10 17:17
FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug(Investor's Business Daily)
- 2024-06-10 10:27
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug(Investor's Business Daily)
- 2024-06-10 10:12
- 2024-06-10 09:54
- 2024-06-10 03:43
Page 1 of 10
previousnext